Pathogenesis of idiopathic parkinsonism
- PMID: 8375434
- DOI: 10.1159/000118533
Pathogenesis of idiopathic parkinsonism
Abstract
Idiopathic parkinsonism (Parkinson's disease) makes up the largest diagnostic subgroup of patients with parkinsonism. Various hypotheses exist regarding the pathogenesis of idiopathic parkinsonism: these include genetic predilection aging, environmental factors, oxidative stress, excitotoxicity, autoimmunity, and trauma. We suggest that the pathogenesis of idiopathic parkinsonism is likely to be multifactorial, deriving from environmental factor(s) acting upon a genetically predisposed individual. Because of the compelling evidence indicating common clinical and pathological findings in idiopathic parkinsonism, Alzheimer's disease, and amyotrophic lateral sclerosis, we believe that these conditions result from pathological processes with more similarity than diversity. A primary glutamatergic cell neocortical abnormality provides an attractive unifying explanation which may explain the overlapping abnormalities found in idiopathic parkinsonism, Alzheimer's disease, and amyotrophic lateral sclerosis.
Similar articles
-
Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis.Neurology. 1991 Oct;41(10):1554-7. doi: 10.1212/wnl.41.10.1554. Neurology. 1991. PMID: 1922795
-
Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?Del Med J. 1987 Aug;59(8):533-4, 537. Del Med J. 1987. PMID: 3666247 No abstract available.
-
Lewy body disease.Curr Opin Neurol Neurosurg. 1992 Dec;5(6):889-94. Curr Opin Neurol Neurosurg. 1992. PMID: 1467583 Review.
-
Common risk factors of three diseases.Ital J Neurol Sci. 1992 Feb;13(1):83. doi: 10.1007/BF02222893. Ital J Neurol Sci. 1992. PMID: 1559788 No abstract available.
-
The neuropathology of parkinsonism: an overview.Brain Cogn. 1995 Aug;28(3):321-41. doi: 10.1006/brcg.1995.1261. Brain Cogn. 1995. PMID: 8546858 Review.
Cited by
-
Parenteral application of NADH in Parkinson's disease: clinical improvement partially due to stimulation of endogenous levodopa biosynthesis.J Neural Transm (Vienna). 1996;103(10):1187-93. doi: 10.1007/BF01271203. J Neural Transm (Vienna). 1996. PMID: 9013405 Clinical Trial.
-
Autoimmunity, dendritic cells and relevance for Parkinson's disease.J Neural Transm (Vienna). 2013 Jan;120(1):75-81. doi: 10.1007/s00702-012-0842-7. Epub 2012 Jun 15. J Neural Transm (Vienna). 2013. PMID: 22699458 Free PMC article. Review.
-
Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.J Neural Transm (Vienna). 2017 Dec;124(12):1529-1537. doi: 10.1007/s00702-017-1799-3. Epub 2017 Nov 7. J Neural Transm (Vienna). 2017. PMID: 29116411 Free PMC article. Review.
-
CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.J Neural Transm (Vienna). 2016 Mar;123(3):179-87. doi: 10.1007/s00702-015-1479-0. Epub 2015 Nov 3. J Neural Transm (Vienna). 2016. PMID: 26526034
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical